Driving stroke quality improvement at scale in EDs across a nationwide network of hospitals: strategies and interventions.
Aged
Aged, 80 and over
Emergency Service, Hospital
/ organization & administration
Female
Hospitals
/ statistics & numerical data
Humans
Male
Middle Aged
Quality Improvement
/ trends
Stroke
/ therapy
Surveys and Questionnaires
Thrombolytic Therapy
/ methods
Time-to-Treatment
/ statistics & numerical data
Tissue Plasminogen Activator
/ therapeutic use
United States
/ epidemiology
management, quality assurance
stroke
thrombolysis
Journal
Emergency medicine journal : EMJ
ISSN: 1472-0213
Titre abrégé: Emerg Med J
Pays: England
ID NLM: 100963089
Informations de publication
Date de publication:
Jul 2019
Jul 2019
Historique:
received:
07
11
2018
revised:
08
04
2019
accepted:
17
04
2019
pubmed:
24
6
2019
medline:
3
1
2020
entrez:
24
6
2019
Statut:
ppublish
Résumé
Reducing the treatment time while increasing the proportion of eligible stroke patients who receive intravenous tissue plasminogen activator (tPA) has been a priority for many quality improvement efforts. Recent studies have primarily focused on identifying interventions that reduce door-to-needle (DTN) time, while comparatively little has been done to determine whether these interventions also improve tPA rates. In order to investigate interventions related to process improvements, an electronic dashboard serving as a stroke performance tool was implemented to store and retrieve patient outcome data. These data were used to study the efficacy of interventions designed to facilitate triage of stroke patients in the ED, and determine the individual interventions associated with the most significant improvements in the fraction of patients receiving tPA and in reducing the DTN time. Stroke performance data from the dashboard collected over a 2-year period (2015-2017) from 89 US hospitals were analysed with respect to interventions implemented by individual facilities, as verified by a hospital survey. A statistically significant association was found between increases in the fraction of patients receiving tPA and reductions in DTN time over the study period. These improvements in outcomes were most strongly associated with process interventions that allocate stroke-specific physical and human resources in the ED, most notably a designated emergency room space for stroke, and with workflows that decrease the time to key checkpoints for determining a patient's eligibility for tPA. Data from the stroke performance tool was leveraged to identify the programmes and process interventions that lead to improved patient outcomes and allow EDs to better prioritise process interventions and resources.
Identifiants
pubmed: 31230040
pii: emermed-2018-208257
doi: 10.1136/emermed-2018-208257
doi:
Substances chimiques
Tissue Plasminogen Activator
EC 3.4.21.68
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
423-430Informations de copyright
© Author(s) (or their employer(s)) 2019. No commercial re-use. See rights and permissions. Published by BMJ.
Déclaration de conflit d'intérêts
Competing interests: None declared.